Suven Life Sciences Limited Stock: price and insider trades · India
Suven Life Sciences Limited: what insiders have been doing
Insider filings for Suven Life Sciences Limited are scarce in the SEBI (PIT + SAST) feed, the latest one published on 9 March 2026. This page will fill in as new trades are disclosed. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 31,768,764 shares@ ₹134.0040.0% of flowEquity SharesSEBI:e0d1c1e64eaa682e89b31f56aeced0f22fae1e71
- 31,768,764 shares@ ₹134.0042.4% of flowWarrantsSEBI:1bc0014005b5ef03ae771fd9be3fde61e29ec01d
- 1,525,535 sharesEquity SharesSEBI:b2a78c8696ed2845805b6f81cf5fca84b27ade99
- 18,100,000 shares@ ₹81.5717.7% of flowEquity SharesSEBI:f53e6efaf3405cf012b1186e13b91fababe44764
4 of 4 declarations
About Suven Life Sciences Limited
Suven Life Sciences Limited is a company focused on the research and development of pharmaceuticals, primarily in the field of neurological and psychiatric disorders. It is listed on the Bombay Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
